Literature DB >> 11209938

The effects of propofol on NMDA- or nitric oxide-mediated neurotoxicity in vitro.

S Shibuta1, V Sriranganathan, T Inoue, T Shimizu, K Tomi, T Mashimo.   

Abstract

Acute brain ischemia causes neurotoxic cascades including NMDA receptors and NO. Propofol, an i.v. anesthetic, is thought to have a neuroprotective effect. We investigated the influence of propofol on NMDA/NO neurotoxicity using Shibuta's established model of primary brain cultures. Cortical neurons prepared from E16 were used after 13-14 days in culture. The neurons were exposed to various concentrations of propofol with NMDA or NO-donor. The survival rates of neurons exposed to 30 microM NMDA with or without 300 microM propofol were 12.1 +/- 2.2% and 11.9 +/- 2.2%, respectively. The survival rates exposed to 30 microM NO-donor with or without 300 microM propofol were 11.2 +/- 4.2% and 14.0 +/- 3.9%, respectively. These results suggest that neuroprotective effect of propofol is limited and propofol does not offer advantages over thiopental against NMDA/NO-induced cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11209938     DOI: 10.1097/00001756-200102120-00023

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  TLR4 signaling is involved in the protective effect of propofol in BV2 microglia against OGD/reoxygenation.

Authors:  Xia Qin; Zhen-Quan Sun; Xue-Wei Zhang; Xiao-Jing Dai; Shan-Shan Mao; Yong-Mei Zhang
Journal:  J Physiol Biochem       Date:  2013-03-20       Impact factor: 4.158

2.  The influence of initial target effect-site concentrations of propofol on the similarity of effect-sites concentrations at loss and return of consciousness in elderly female patients with the Diprifusor system.

Authors:  Satoshi Shibuta; Seitetsu Kanemura; Osamu Uchida; Takashi Mashimo
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-04

3.  Effect of preconditioning on propofol-induced neurotoxicity during the developmental period.

Authors:  Satoshi Shibuta; Tomotaka Morita; Jun Kosaka
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.